期刊文献+

妊娠期孕妇亚临床甲减对妊娠结局的影响分析 被引量:8

Analysis of Pregnancy Outcome of Pregnant Women with Subclinical Hypothyroidism during Pregnancy
在线阅读 下载PDF
导出
摘要 目的分析妊娠期孕妇亚临床甲减对妊娠结局的影响,为临床提供指导。方法随机抽取入住该院的60例妊娠期亚临床甲减孕妇(2011年12月—2015年12月)作为该次实验的研究对象,对60例妊娠期亚临床甲减孕妇实施计算机随机分组(对照组和观察组)。对照组30例妊娠期亚临床甲减孕妇不实施药物治疗,观察组30例妊娠期亚临床甲减孕妇实施药物治疗,分析比较两组妊娠期亚临床甲减孕妇治疗前后血清游离甲状腺素(FT4)、血清游离三碘甲状腺原氨酸(FT3)、促甲状腺激素(TSH)情况、妊娠结局及新生儿不良结局发生情况。结果对照组妊娠期亚临床甲减孕妇的并发症发生率(53.33%)显著高于观察组(13.33%),且观察组妊娠期亚临床甲减孕妇治疗后FT4、FT3、TSH水平分别为(13.67±1.61)pmol/L、(6.87±0.81)pmol/L、(3.51±1.09)m U/L,新生儿不良结局发生率为10.00%,对照组妊娠期亚临床甲减孕妇治疗后FT4、FT3、TSH水平分别为(11.13±1.45)pmol/L、(5.06±0.51)pmol/L、(8.24±1.57)m U/L,新生儿不良结局发生率为40.00%,比较可知,观察组和对照组妊娠期亚临床甲减孕妇治疗后FT4、FT3、TSH情况以及新生儿不良结局发生率对比差异有统计学意义,P<0.05。结论妊娠期亚临床甲减易增加孕妇发生并发症的机率以及新生儿不良结局发生率,为保证母婴安全,临床应对孕妇实施有效治疗。 Objective To analyze pregnancy pregnant women subclinical Jia Jian influence on pregnancy outcome, provide guidance for clinical. Methods Random selection 60 patients admitted to the hospital subclinical Jia Jian pregnant women during pregnancy(December 2011 to December 2015) as the research object of this experiment, 60 cases of subclinical JiaJian pregnant women during pregnancy to implement computer random group(control group and observation group). Control group 30 cases of subclinical Jia Jian pregnant women during pregnancy does not implement drug treatment, the experimental group 30 cases of subclinical Jia Jian pregnant women during pregnancy to implement drug treatment, compared two groups of subclinical Jia Jian during pregnancy pregnant women before and after treatment serum free thyroxine(FT4), serum free thyroid original three iodine glycine(FT3) and testing for thyroid-stimulating hormone(TSH), pregnancy outcome and neonatal adverse outcomes happen. Results In the control group of subclinical Jia Jian pregnant women during pregnancy complications(53.33%) is significantly higher than the experimental group(13.33%), and the observation group, the gestation period of sub clinical hypothyroidism after treatment for pregnant women, FT4, FT3, and TSH levels respectively(13.67±1.61) pmol/L,(6.87±0.81) pmol/L,(3.51±1.09) m U/L, adverse neonatal outcomes occur rate was 10.00%, control group pregnancy sub clinical hypothyroidism after treatment for pregnant women, FT4, FT3, and TSH levels respectively(11.13±1.45)pmol/L,(5.06±0.51) pmol/L,(8.24±1.57) m U/L, adverse neonatal outcomes occurred rate was 40.00%. the comparison shows that,and the experimental group and control group in subclinical Jia Jian pregnant women during pregnancy after treatment,FT4, FT3, TSH and incidence of neonatal adverse outcome exists obvious difference, P < 0.05. Conclusion Pregnancy subclinical Jia Jian easy to raise the risk of pregnant complications incidence and neonatal adverse outcomes, in order to ensure the safety of maternal and infant clinical response to pregnant women to carry out effective treatment.
作者 曾昭良
出处 《中外医疗》 2016年第28期7-9,15,共4页 China & Foreign Medical Treatment
关键词 妊娠期孕妇 亚临床甲减 妊娠结局 影响 Pregnant women during pregnancy Subclinical Jia Jian Pregnancy outcome Impact
  • 相关文献

参考文献7

二级参考文献114

  • 1何丽萍.孕妇甲状腺功能异常对妊娠结局的影响[J].中国综合临床,2005,21(3):273-275. 被引量:27
  • 2张宏,白景文,赵伟,郑凝,董如娇,卫丽君,方佩华.糖尿病大鼠甲状腺组织的超微病理改变[J].天津医药,2006,34(2):108-110. 被引量:40
  • 3单忠艳,滕卫平.甲状腺疾病与妊娠[J].国际内分泌代谢杂志,2006,26(5):295-302. 被引量:104
  • 4缪婕,赵咏桔.亚临床甲状腺功能减退症与妊娠[J].国际内分泌代谢杂志,2006,26(5):348-350. 被引量:19
  • 5卢昆林,曹清,叶琳.妊娠糖尿病对母婴影响的分析[J].中国优生与遗传杂志,2007,15(6):60-60. 被引量:13
  • 6Pop V J, Brouwers EP, Vader HL, et al. Maternal hypothy- roxinaemia during early pregnancy and subsequent child devel- opment: a 3 year follow up study [J . Clin Endocrinol, 2003, 59 (3): 282.
  • 7Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothy- roidism and pregnancy outcomes [J ] . Obstet Gynecol, 2005, 105 (2): 239.
  • 8李美珍,聂玉香,吕娜,等.亚临床甲减的早期干预在妊娠期妇女中的临床价值[J].中外健康文摘,2012,9(5):193.
  • 9Wier FA, Farley CL. Clinical controversies in screening women for thyroid disorders during pregnancy [ J . J Midwifery Womens Health, 2006, 51 (3) : 152.
  • 10Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline [J]. Clin Endoerinol Metab, 2007,92 (8 Suppl) : S1-47.

共引文献170

同被引文献66

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部